AbbVie Inc. is 211.9x more valuable than Lakefront Biotherapeutics NV by market capitalization ($399.47 B vs $1.89 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LKFT | ABBV |
|---|---|---|
| Market cap | $1.89 B | $399.47 B |
| US-listed rank | #2137 | #28 |
| Revenue (latest FY) | - | $61.16B |
| Net income (latest FY) | - | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 511 | 1,008 |
AbbVie Inc. is 211.9x more valuable than Lakefront Biotherapeutics NV by market capitalization ($399.47 B vs $1.89 B).
Full pages: Lakefront Biotherapeutics NV and AbbVie Inc., or browse the full rankings.